Metabolic Syndrome and Transplantation

Reaven, 1988, Banting lecture 1988. Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 de Vries, 2004, Metabolic syndrome is associated with impaired long‐term renal allograft function; not all component criteria contribute equally, Am J Transplant, 4, 1675, 10.1111/j.1600-6143.2004.00558.x Rodrigo, 2006, New‐onset diabetes after kidney transplantation: Risk factors, J Am Soc Nephrol, 17, S291, 10.1681/ASN.2006080929 Armstrong, 2005, Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients, Am J Transplant, 5, 2710, 10.1111/j.1600-6143.2005.01073.x Hjelmesaeth, 2006, Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy, Clin J Am Soc Nephrol, 1, 575, 10.2215/CJN.01471005 Nishimura, 2009, Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new‐onset diabetes after renal transplantation: Single‐center cross‐sectional analysis, Transpl Int, 22, 694, 10.1111/j.1432-2277.2009.00849.x Genis, 2007, Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation, Transplantation, 84, 1248, 10.1097/01.tp.0000287456.82676.01 von Eynatten, 2008, Atherogenic dyslipidaemia but not total‐ and high‐molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease, Eur Heart J, 29, 1307, 10.1093/eurheartj/ehn135 Rodrigo, 2002, Apolipoprotein C‐III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation, Am J Transplant, 2, 343, 10.1034/j.1600-6143.2002.20409.x Alberti, 1998, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S Balkau, 2002, Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome, Diabetes Metab, 28, 364 Grundy, 2004, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition, Circulation, 109, 433, 10.1161/01.CIR.0000111245.75752.C6 Alberti, 2006, Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation, Diabet Med, 23, 469, 10.1111/j.1464-5491.2006.01858.x Wilson, 2005, Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus, Circulation, 112, 3066, 10.1161/CIRCULATIONAHA.105.539528 Ho, 2008, Relation of the number of metabolic syndrome risk factors with all‐cause and cardiovascular mortality, Am J Cardiol, 102, 689, 10.1016/j.amjcard.2008.05.010 Jaggers, 2009, Metabolic syndrome and risk of cancer mortality in men, Eur J Cancer, 45, 1831, 10.1016/j.ejca.2009.01.031 Nabipour, 2006, The association of metabolic syndrome and Chlamydia pneumoniae Helicobacter pylori cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study, Cardiovasc Diabetol, 5, 25, 10.1186/1475-2840-5-25 Porrini, 2006, Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation, Am J Kidney Dis, 48, 134, 10.1053/j.ajkd.2006.04.078 Hanouneh, 2008, The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation, Liver Transpl, 14, 1287, 10.1002/lt.21524 Courivaud, 2007, Metabolic syndrome and atherosclerotic events in renal transplant recipients, Transplantation, 83, 1577, 10.1097/01.tp.0000266898.93894.3d Laryea, 2007, Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events, Liver Transpl, 13, 1109, 10.1002/lt.21126 Armstrong, 2006, Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose‐intolerant renal transplant recipients, Clin J Am Soc Nephrol, 1, 1275, 10.2215/CJN.00210106 Adeseun, 2008, Metabolic syndrome and coronary artery calcification in renal transplant recipients, Transplantation, 86, 728, 10.1097/TP.0b013e3181826d12 Reaven, 2006, The metabolic syndrome: Is this diagnosis necessary?, Am J Clin Nutr, 83, 1237, 10.1093/ajcn/83.6.1237 Gami, 2007, Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta‐analysis of longitudinal studies, J Am Coll Cardiol, 49, 403, 10.1016/j.jacc.2006.09.032 Kasiske, 1996, Cardiovascular disease after renal transplantation, J Am Soc Nephrol, 7, 158, 10.1681/ASN.V71158 Sharif A, Ravindran V, Dunseath G, Luzio S, Owens D, BaboolalK. Comparison of rival metabolic syndrome classifications against pathophysiological markers in renal transplant recipients. Transplantation 2009 (in press). Sharif A, Ravindran V, Moore R et al. Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. Transplantation 2009 (in press). United States Renal Data System. USRDS 2008 Annual Data Report 2008; Available from: http://www.usrds.org.2008. Gaston, 2009, Use of cardioprotective medications in kidney transplant recipients, Am J Transplant, 9, 1811, 10.1111/j.1600-6143.2009.02696.x